Efficacy and Safety of Pactimibe in Patients With Atherosclerosis

PHASE2CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

September 30, 2002

Study Completion Date

August 31, 2005

Conditions
Atherosclerosis
Interventions
DRUG

Pactimibe

Trial Locations (1)

Unknown

Munich

All Listed Sponsors
lead

Sankyo Pharma Gmbh

INDUSTRY

NCT00185146 - Efficacy and Safety of Pactimibe in Patients With Atherosclerosis | Biotech Hunter | Biotech Hunter